Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Aspira Women's Health enrolls first patient in OVANex study » 08:21
06/29/20
06/29
08:21
06/29/20
08:21
AWH

Aspira Women's Health

$5.30 /

+0.31 (+6.21%)

, VRML

Vermillion

$0.00 /

+ (+0.00%)

Aspira Women's…

Aspira Women's Health announced the first patient enrolled in a national clinical study of benign pelvic mass management. The study will enroll over 1,000 women for assessing ovarian cancer risk in women who have an adnexal mass and a high probability for developing the disease. In this recently launched study, ovarian cancer risk will be assessed by a newly developed, multi-biomarker, proprietary algorithm based on AWH's experience and vast specimen bank in developing algorithms and FDA-cleared products for assessing ovarian cancer risk. This study will enroll women in three distinct cohorts; women with pelvic masses without symptoms, women with pelvic masses with indeterminate symptoms, and women without pelvic masses that are high risk for ovarian cancer due to hereditary genetic risk. The primary objective is to determine which patients are low risk and can be monitored without surgery, and which women are at higher risk and need to be sent for further clinical assessment.

ShowHide Related Items >><<
VRML Vermillion
$0.00 /

+ (+0.00%)

AWH Aspira Women's Health
$5.30 /

+0.31 (+6.21%)

AWH Aspira Women's Health
$5.30 /

+0.31 (+6.21%)

VRML Vermillion
$0.00 /

+ (+0.00%)

12/16/19
Vermillion management to meet with William Blair
AWH Aspira Women's Health
$5.30 /

+0.31 (+6.21%)

Options
Two new option listings and two option delistings on June 12th » 08:30
06/12/20
06/12
08:30
06/12/20
08:30
AWH

Aspira Women's Health

$4.02 /

-0.3 (-6.94%)

, VTOL

Bristow Group

$5.20 /

-1.05 (-16.80%)

, ERA

Era Group

/

+

, VRML

Vermillion

/

+

New option listings for…

New option listings for June 12th include Aspira Womans Health Inc (AWH) and Bristow Group Inc (VTOL). Option delistings effective June 12th include Era Group Inc (When Issued) (ERA) and Vermillion Inc (VRML).

ShowHide Related Items >><<
VTOL Bristow Group
$5.20 /

-1.05 (-16.80%)

VRML Vermillion
/

+

ERA Era Group
/

+

AWH Aspira Women's Health
$4.02 /

-0.3 (-6.94%)

AWH Aspira Women's Health
$4.02 /

-0.3 (-6.94%)

VTOL Bristow Group
$5.20 /

-1.05 (-16.80%)

ERA Era Group
/

+

03/09/20 Evercore ISI
Era Group downgraded to In Line from Outperform at Evercore ISI
VRML Vermillion
/

+

12/16/19
Vermillion management to meet with William Blair
ERA Era Group
/

+

Hot Stocks
Vermillion rebrands, changes name to Aspira Women's Health » 08:41
06/11/20
06/11
08:41
06/11/20
08:41
AWH

Aspira Women's Health

$0.00 /

+ (+0.00%)

, VRML

Vermillion

$4.32 /

-0.175 (-3.89%)

Vermillion announced a…

Vermillion announced a major rebranding to reflect the company's continuing evolution towards becoming a comprehensive gynecologic health company, including a corporate name change to Aspira Women's Health Inc effective today, June 11, 2020. The company's common stock will trade on the Nasdaq Stock Market under the new ticker symbol "AWH" effective June 12, 2020. Over the past 12 months, Aspira Women's Health has established its foundation as the market leader for ovarian cancer risk assessment while beginning product development to expand into large benign gynecologic disease markets. The company's goal is to serve the large pelvic mass market, 20 million women in the US, and 200 million women worldwide, with proprietary products throughout the entire patient lifecycle. The Company has experienced an increase in its US customer base of ordering physicians from 1,400 in 2018 to 2,700 for 2019, a 56% increase. The Company has 85 filed and 40 pending patents. This growth reflects the trust and adoption of OVA1 plus coupled with real-time innovations such as the addition of germline genetic testing and ethnic disparity solutions. Portfolio expansion development includes: pelvic mass monitoring, endometriosis, and high-risk ovarian cancer screening for those genetically predisposed. As part of the name change, the company has a new stock ticker symbol and a new CUSIP and has relaunched its website as www.aspirawh.com, and rolled out a new company logo and associated icon pictorially connecting the dots for gynecologic women's health. The company has used the name, "Vermillion Inc." for more than 13 years, during which it has been known for developing FDA cleared ovarian cancer risk assessment tests OVA1 and OVERA. The name change will not affect the quality of products or services offered by the company. The Company anticipates holding a conference call later this month to discuss the rebranding and expanded portfolio. Details of the call will follow on a later date.

ShowHide Related Items >><<
VRML Vermillion
$4.32 /

-0.175 (-3.89%)

AWH Aspira Women's Health
$0.00 /

+ (+0.00%)

VRML Vermillion
$4.32 /

-0.175 (-3.89%)

12/16/19
Vermillion management to meet with William Blair
Hot Stocks
Vermillion completes validation of pre-surgical test offerings » 08:07
06/10/20
06/10
08:07
06/10/20
08:07
VRML

Vermillion

$4.49 /

+0.64 (+16.62%)

Vermillion announced that…

Vermillion announced that its wholly-owned subsidiary ASPIRA Labs has completed laboratory validation of the Roche Elecsys Anti-SARS-CoV-2 antibody test for detecting the presence of COVID-19 antibodies. Our Laboratory has also completed validation of several additional oncology biomarkers. Both the COVID-19 antibody test and additional biomarkers will be used in an ASPIRA pelvic mass risk assessment pre-surgery workup. ASPIRA Labs selected to validate the Roche Elecsys Anti-SARS-CoV-2 antibody test because it detects both IgG and IgM antibodies. Testing for IgG and IgM antibodies yields a specificity of 99.81% and a sensitivity of 100%. The completed validation of COVID-19 antibody and additional pelvic mass risk assessment biomarkers will be offered commercially by the end of June in conjunction with our proprietary OVA1(R)plus test. The additional oncology biomarkers are CEA, CA19.9, LDH, Beta HCG, and AFP. These laboratory tests are essential in helping physicians identify less frequent ovarian tumor types as part of the pre-surgical workup.

ShowHide Related Items >><<
VRML Vermillion
$4.49 /

+0.64 (+16.62%)

VRML Vermillion
$4.49 /

+0.64 (+16.62%)

12/16/19
Vermillion management to meet with William Blair
Over a quarter ago
Hot Stocks
Vermillion says ASPiRA LABS now credentialed as Florida medicaid provider » 08:26
04/14/20
04/14
08:26
04/14/20
08:26
VRML

Vermillion

$1.09 /

+0.1679 (+18.31%)

Vermillion announced its…

Vermillion announced its wholly owned subsidiary, ASPiRA LABS, is now credentialed with Florida's State Medicaid program for an estimated additional 3.6 million credentialed Medicaid lives. Florida has the fourth largest state Medicaid populations in the U.S. and ASPiRA is now credentialed in 4 of the top 5 states by Medicaid population size, including California, Pennsylvania, Texas and now Florida. The state of New York has the second largest state Medicaid population and ASPiRA LABS is in process of seeking credentials there. Florida brings the total credentialed Medicaid population to almost 50 M Medicaid lives, which is about 77% of the U.S. Medicaid population. This credentialing also allows ASPiRA LABS to seek participation as a network provider with commercial Medicaid health plans. ASPiRA LABS is the only U.S. provider for Vermillion's proprietary OVA1 test, an FDA-cleared, ACOG recommended and CMS supported ovarian cancer risk assessment for women with a pelvic mass.

ShowHide Related Items >><<
VRML Vermillion
$1.09 /

+0.1679 (+18.31%)

12/16/19
Vermillion management to meet with William Blair
Hot Stocks
Vermillion announces Cigna preferred contract coverage for OVA1, Overa » 08:09
03/27/20
03/27
08:09
03/27/20
08:09
VRML

Vermillion

$0.74 /

+0.0391 (+5.58%)

, CI

Cigna

$169.42 /

+12.69 (+8.10%)

Vermillion, Inc. (VRML)…

Vermillion, Inc. (VRML) announced yesterday that its wholly owned subsidiary, ASPiRA Labs, has signed a national preferred agreement with Cigna (CI). This contract includes OVA1, an ACOG endorsed ovarian cancer risk assessment test, as well as Overa and all genetic testing offered by ASPiRA. This agreement with Cigna will expand ASPiRA Labs contracted coverage by an additional 16 million lives.

ShowHide Related Items >><<
VRML Vermillion
$0.74 /

+0.0391 (+5.58%)

12/16/19
Vermillion management to meet with William Blair
CI Cigna
$169.42 /

+12.69 (+8.10%)

03/24/20 Raymond James
Cigna upgraded to Strong Buy from Outperform at Raymond James
03/24/20 Raymond James
Cigna upgraded to Strong Buy from Outperform at Raymond James
03/23/20 Raymond James
Cigna price target lowered to $210 from $240 at Raymond James
03/13/20 Cowen
Cigna remains a Best Idea and To Pick, says Cowen
Conference/Events
EBDF Group to hold a conference » 04:55
01/15/20
01/15
04:55
01/15/20
04:55
A

Agilent

$88.02 /

+0.565 (+0.65%)

, AGE

AgeX Therapeutics

$1.85 /

+0.13 (+7.56%)

, ALNY

Alnylam

$118.48 /

+3.68 (+3.21%)

, AZN

AstraZeneca

$50.18 /

+0.5 (+1.01%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, BCLI

BrainStorm

$4.34 /

-0.04 (-0.91%)

, ENTX

Entera Bio

$2.78 /

-0.03 (-1.07%)

, DYAI

Dyadic International

$5.50 /

-0.135 (-2.40%)

, DTIL

Precision BioSciences

$13.40 /

-0.12 (-0.89%)

, DD

DuPont

$60.16 /

-0.25 (-0.41%)

, CYCC

Cyclacel Pharmaceuticals

$0.74 /

-0.0549 (-6.91%)

, CTLT

Catalent

$60.34 /

+0.88 (+1.48%)

, COWN

Cowen Group

$16.34 /

-0.2 (-1.21%)

, GMAB

Genmab

$22.44 /

-0.21 (-0.93%)

, IDXG

Interpace Biosciences

$0.62 /

+ (+0.00%)

, LCTX

Lineage Cell Therapeutics

$0.75 /

-0.0146 (-1.92%)

, PHIO

Phio Pharmaceuticals

$0.20 /

+0.0117 (+6.35%)

, PJC

Symbol now PIPR

$0.00 /

+ (+0.00%)

, TNXP

Tonix Pharmaceuticals

$1.48 /

+0.03 (+2.07%)

, TROV

Changed name to CRDF

$1.47 /

+0.15 (+11.41%)

, VCYT

Veracyte

$28.58 /

+0.17 (+0.60%)

, VIE

Viela Bio

$37.10 /

+4.17 (+12.66%)

, PSTV

Plus Therapeutics

$2.81 /

+0.02 (+0.72%)

, RDUS

Radius Health

$20.14 /

+1.77 (+9.64%)

, MRNA

Moderna

$20.01 /

-0.21 (-1.04%)

, MRK

Merck

$89.93 /

+0.5 (+0.56%)

, NAVB

Navidea

$1.49 /

-0.03 (-1.97%)

, NBSE

NeuBase Therapeutics

$6.31 /

-0.19 (-2.92%)

, NVO

Novo Nordisk

$59.62 /

+0.66 (+1.12%)

, NVS

Novartis

$94.47 /

+0.765 (+0.82%)

, OVID

Ovid Therapeutics

$3.59 /

+0.09 (+2.57%)

, STI

Merged to become TFC

$0.00 /

+ (+0.00%)

, XON

Intrexon

$7.20 /

+0.46 (+6.82%)

, SLRX

Salarius Pharmaceuticals

$3.20 /

+0.15 (+4.92%)

, VVUS

VIVUS

$2.72 /

-0.01 (-0.37%)

, SIVB

SVB Financial

$253.42 /

-0.36 (-0.14%)

, VRML

Vermillion

$0.79 /

-0.0453 (-5.39%)

, VKTX

Viking Therapeutics

$7.36 /

+0.045 (+0.62%)

Biotech Showcase 2020…

Biotech Showcase 2020 will be held in San Francisco on January 13-15.

ShowHide Related Items >><<
A Agilent
$88.02 /

+0.565 (+0.65%)

01/07/20 Wells Fargo
Wells Fargo initiates Life Science Tools, Services, Diagnostics Sector
01/07/20 Wells Fargo
Agilent initiated with an Overweight at Wells Fargo
01/06/20 Citi
Agilent initiated with a Neutral at Citi
11/26/19 JPMorgan
Agilent price target raised to $90 from $85 at JPMorgan
AGE AgeX Therapeutics
$1.85 /

+0.13 (+7.56%)

ALNY Alnylam
$118.48 /

+3.68 (+3.21%)

12/18/19 Cantor Fitzgerald
Alnylam price target raised to $176 from $159 at Cantor Fitzgerald
12/17/19 Piper Sandler
Alnylam price target raised to $155 from $145 at Piper Jaffray
11/25/19 Stifel
Alnylam one of few mid-caps with 'plausible large-cap aspirations,' says Stifel
11/25/19 BMO Capital
Alnylam price target raised to $143 from $138 at BMO Capital
AZN AstraZeneca
$50.18 /

+0.5 (+1.01%)

01/13/20 Roth Capital
Amarin's Vascepa now the 'go-to' after competitor failures, says Roth Capital
01/13/20 Stifel
Amarin should rally on failure of two potential competitors, says Stifel
01/13/20 JPMorgan
Epanova discontinuation positive for Amarin, says JPMorgan
12/26/19 Stifel
Stifel sees path to $230 for Iqvia shares after 'significant' AstraZeneca win
BAYRY Bayer
$0.00 /

+ (+0.00%)

12/19/19 BofA
Elanco upgraded to Buy from Neutral at BofA/Merrill
12/17/19 Berenberg
Bayer upgraded to Buy from Hold at Berenberg
12/17/19 Berenberg
Bayer upgraded to Buy from Hold at Berenberg
10/21/19 Piper Sandler
Piper reiterates Overweight on Crispr Therapeutics with $100 price target
BCLI BrainStorm
$4.34 /

-0.04 (-0.91%)

ENTX Entera Bio
$2.78 /

-0.03 (-1.07%)

DYAI Dyadic International
$5.50 /

-0.135 (-2.40%)

10/16/19 Dawson James
Dyadic International initiated with a Buy at Dawson James
DTIL Precision BioSciences
$13.40 /

-0.12 (-0.89%)

09/16/19 H.C. Wainwright
Precision IND accepted a quarter sooner than expected, says H.C. Wainwright
08/09/19 BTIG
Precision BioSciences initiated with a Buy at BTIG
08/09/19 BTIG
Precision BioSciences initiated with a Buy at BTIG
04/22/19 Jefferies
Precision BioSciences initiated with a Buy at Jefferies
DD DuPont
$60.16 /

-0.25 (-0.41%)

01/14/20
Fly Intel: Top five analyst initiations
01/14/20 BMO Capital
DuPont price target lowered to $82 from $87 at BMO Capital
01/14/20 Gordon Haskett
DuPont initiated with a Buy at Gordon Haskett
01/08/20 Spin-Off Research
DuPont upgraded to Buy from Hold at Spin-Off Research
CYCC Cyclacel Pharmaceuticals
$0.74 /

-0.0549 (-6.91%)

CTLT Catalent
$60.34 /

+0.88 (+1.48%)

10/17/19 Stephens
Catalent resumed with an Overweight at Stephens
08/28/19
Fly Intel: Top five analyst downgrades
08/28/19 Baird
Catalent price target raised to $60 from $50 at Baird
08/28/19
Catalent downgraded to Sector Weight on valuation at KeyBanc
COWN Cowen Group
$16.34 /

-0.2 (-1.21%)

07/23/19 Buckingham
Cowen Group initiated with a Buy at Buckingham
GMAB Genmab
$22.44 /

-0.21 (-0.93%)

01/13/20 Truist
Genmab initiated with a Buy at SunTrust
01/02/20 Guggenheim
Incyte downgraded to Neutral after strong 2019 at Guggenheim
12/12/19 Deutsche Bank
Genmab downgraded to Hold from Buy at Deutsche Bank
10/04/19 Guggenheim
Guggenheim positively biased on Biotech heading into earnings
IDXG Interpace Biosciences
$0.62 /

+ (+0.00%)

09/25/19 Oppenheimer
Oppenheimer starts Interpace at Outperform, sees 'clear path to BioPharma'
09/25/19 Oppenheimer
Interpace Diagnostics initiated with an Outperform at Oppenheimer
LCTX Lineage Cell Therapeutics
$0.75 /

-0.0146 (-1.92%)

PHIO Phio Pharmaceuticals
$0.20 /

+0.0117 (+6.35%)

PJC Symbol now PIPR
$0.00 /

+ (+0.00%)

10/04/19 Buckingham
Piper Jaffray initiated with a Neutral at Buckingham
10/04/19 Buckingham
Piper Jaffray initiated with a Neutral rating at Buckingham
TNXP Tonix Pharmaceuticals
$1.48 /

+0.03 (+2.07%)

08/30/19 Roth Capital
Tonix Pharmaceuticals price target lowered to $1.30 from $4 at Roth Capital
04/18/19
Tonix Pharmaceuticals upgraded to Buy at Roth Capital
04/18/19 Roth Capital
Tonix Pharmaceuticals upgraded to Buy from Neutral at Roth Capital
TROV Changed name to CRDF
$1.47 /

+0.15 (+11.41%)

03/01/19 Maxim
Trovagene price target lowered to $8 from $18 at Maxim
VCYT Veracyte
$28.58 /

+0.17 (+0.60%)

12/04/19 Lake Street
Veracyte answered key question with NanoString pact, says Lake Street
07/31/19
Fly Intel: Top five analyst initiations
07/31/19 Lake Street
Veracyte initiated with a Buy at Lake Street
07/02/19
Fly Intel: Top five analyst initiations
VIE Viela Bio
$37.10 /

+4.17 (+12.66%)

10/28/19 Guggenheim
Guggenheim starts Viela Bio at Buy, makes stock Best Idea
10/28/19 Morgan Stanley
Viela Bio initiated with an Overweight at Morgan Stanley
10/28/19 Cowen
Viela Bio initiated with an Outperform at Cowen
10/28/19 Goldman Sachs
Viela Bio initiated with a Buy at Goldman Sachs
PSTV Plus Therapeutics
$2.81 /

+0.02 (+0.72%)

RDUS Radius Health
$20.14 /

+1.77 (+9.64%)

11/06/19 SVB Leerink
Radius Health price target lowered to $35 from $49 at SVB Leerink
08/29/19 Citi
Radius Health upgraded to Buy from Neutral at Citi
05/30/19 Citi
Radius Health assumed with a Neutral at Citi
05/29/19 Goldman Sachs
Radius Health upgraded to Buy from Neutral at Goldman Sachs
MRNA Moderna
$20.01 /

-0.21 (-1.04%)

01/10/20 Roth Capital
Moderna 'inching closer to a blockbuster CMV vaccine,' says Roth Capital
12/03/19 BofA
Moderna resumed with a Buy at BofA/Merrill
10/25/19 Roth Capital
Moderna initiated with a Buy at Roth Capital
09/13/19 Piper Sandler
Moderna price target raised to $32 from $30 at Piper Jaffray
MRK Merck
$89.93 /

+0.5 (+0.56%)

01/07/20
Fly Intel: Top five analyst initiations
01/07/20 SVB Leerink
OS miss in 1L SCLC 'a disappointing start to 2020' for Merck, says SVB Leerink
01/06/20 RBC Capital
Merck initiated with a Sector Perform at RBC Capital
12/18/19 Morgan Stanley
Morgan Stanley upgrades Major Pharmaceuticals sector view to Attractive
NAVB Navidea
$1.49 /

-0.03 (-1.97%)

11/22/19 H.C. Wainwright
Navidea initiated with a Buy at H.C. Wainwright
07/11/19
Fly Intel: Top five analyst initiations
07/11/19 Maxim
Navidea initiated with a Buy at Maxim
07/11/19 Maxim
Navidea initiated with a Buy at Maxim
NBSE NeuBase Therapeutics
$6.31 /

-0.19 (-2.92%)

11/20/19 Oppenheimer
NeuBase Therapeutics initiated with an Outperform at Oppenheimer
10/29/19 H.C. Wainwright
NeuBase Therapeutics initiated with a Buy at H.C. Wainwright
09/24/19 BTIG
NeuBase Therapeutics initiated with a Buy at BTIG
NVO Novo Nordisk
$59.62 /

+0.66 (+1.12%)

01/03/20 Guggenheim
Novo Nordisk downgraded to Neutral on continued insulin headwinds at Guggenheim
01/03/20 Guggenheim
Novo Nordisk downgraded to Neutral from Buy at Guggenheim
11/22/19 Pareto
Novo Nordisk downgraded to Hold from Buy at Pareto
11/19/19 Truist
Dicerna price target raised to $28 from $24 at SunTrust
NVS Novartis
$94.47 /

+0.765 (+0.82%)

01/06/20 JPMorgan
JPMorgan upgrades Sanofi to Overweight on 'unjustified' valuation gap
12/18/19 H.C. Wainwright
Aduro Biotech price target lowered to $4 from $7 at H.C. Wainwright
12/16/19 Evercore ISI
Evercore downgrades Regeneron on Eylea risk from Beovu
12/16/19
Novartis ends development of fevipiprant in asthma after Phase III failure
OVID Ovid Therapeutics
$3.59 /

+0.09 (+2.57%)

09/24/19 Citi
Ovid Therapeutics price target raised to $10 from $8 at Citi
09/23/19 Piper Sandler
Piper says Ovid shares reflect little value for 'exciting' soticlestat program
09/04/19 RBC Capital
Ovid Therapeutics initiated with an Outperform at RBC Capital
03/10/19 Piper Sandler
Ovid Therapeutics price target lowered to $14 from $20 at Piper Jaffray
STI Merged to become TFC
$0.00 /

+ (+0.00%)

12/09/19 RBC Capital
PNC Financial downgraded to Outperform from Top Pick at RBC Capital
11/20/19 Janney Montgomery Scott
SunTrust downgraded to Neutral from Buy at Janney Montgomery Scott
11/11/19 Janney Montgomery Scott
Janney Montgomery Scott downgrades BB&T to Neutral, says premium may 'flatten'
10/08/19 Jefferies
Jefferies changes five bank ratings after looking into 2020, 2021
XON Intrexon
$7.20 /

+0.46 (+6.82%)

06/18/19 JMP Securities
Surterra cannabinoid pact a positive for Intrexon, says JMP Securities
03/01/19 Northland
Intrexon downgraded to Market Perform from Outperform at Northland
SLRX Salarius Pharmaceuticals
$3.20 /

+0.15 (+4.92%)

VVUS VIVUS
$2.72 /

-0.01 (-0.37%)

SIVB SVB Financial
$253.42 /

-0.36 (-0.14%)

01/09/20 BofA
SVB Financial named top pick for 2020 at BofA
01/09/20 BofA
Amazaon, Wix.com, & SVB Financial added to US 1 List at BofA
01/02/20 Truist
SunTrust raises price targets on select regional banks on improved margins
08/13/19 JPMorgan
JPMorgan sees 'tremendous buying opportunity' into SVB Financial shares
VRML Vermillion
$0.79 /

-0.0453 (-5.39%)

12/16/19
Vermillion management to meet with William Blair
VKTX Viking Therapeutics
$7.36 /

+0.045 (+0.62%)

11/21/19 Truist
Viking posting for VOYAGER includes 'nothing concerning,' says SunTrust
07/15/19 Oppenheimer
Viking Therapeutics initiated with an Outperform at Oppenheimer
06/25/19 Stifel
Viking Therapeutics initiated with a Buy at Stifel
06/25/19 Stifel
Madrigal Pharmaceuticals initiated with a Hold at Stifel
Conference/Events
EBDF Group to hold a conference » 04:55
01/14/20
01/14
04:55
01/14/20
04:55
A

Agilent

$87.45 /

-0.19 (-0.22%)

, AGE

AgeX Therapeutics

$1.72 /

-0.15 (-8.02%)

, ALNY

Alnylam

$114.80 /

-4.57 (-3.83%)

, AZN

AstraZeneca

$49.68 /

-0.17 (-0.34%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, BCLI

BrainStorm

$4.38 /

+0.01 (+0.23%)

, ENTX

Entera Bio

$2.81 /

+0.13 (+4.85%)

, DYAI

Dyadic International

$5.64 /

-0.055 (-0.97%)

, DTIL

Precision BioSciences

$13.52 /

-1.19 (-8.09%)

, DD

DuPont

$60.41 /

+0.7 (+1.17%)

, CYCC

Cyclacel Pharmaceuticals

$0.80 /

-0.115 (-12.64%)

, CTLT

Catalent

$59.46 /

+1.77 (+3.07%)

, COWN

Cowen Group

$16.54 /

+0.24 (+1.47%)

, GMAB

Genmab

$22.65 /

-0.02 (-0.09%)

, IDXG

Interpace Biosciences

$0.62 /

-0.0289 (-4.45%)

, LCTX

Lineage Cell Therapeutics

$0.76 /

-0.002 (-0.26%)

, PHIO

Phio Pharmaceuticals

$0.18 /

-0.0225 (-10.95%)

, PJC

Symbol now PIPR

$0.00 /

+ (+0.00%)

, TNXP

Tonix Pharmaceuticals

$1.45 /

-0.14 (-8.81%)

, TROV

Changed name to CRDF

$1.32 /

+0.075 (+6.05%)

, VCYT

Veracyte

$28.41 /

-0.49 (-1.70%)

, VIE

Viela Bio

$32.93 /

+2.84 (+9.44%)

, PSTV

Plus Therapeutics

$2.79 /

-0.05 (-1.76%)

, RDUS

Radius Health

$18.37 /

-1.05 (-5.41%)

, MRNA

Moderna

$20.22 /

+1.12 (+5.86%)

, MRK

Merck

$89.43 /

-0.08 (-0.09%)

, NAVB

Navidea

$1.52 /

+ (+0.00%)

, NBSE

NeuBase Therapeutics

$6.50 /

-0.51 (-7.28%)

, NVO

Novo Nordisk

$58.96 /

+0.27 (+0.46%)

, NVS

Novartis

$93.71 /

-0.165 (-0.18%)

, OVID

Ovid Therapeutics

$3.50 /

-0.35 (-9.09%)

, STI

Merged to become TFC

$0.00 /

+ (+0.00%)

, XON

Intrexon

$6.74 /

+0.3 (+4.66%)

, SLRX

Salarius Pharmaceuticals

$3.05 /

-0.58 (-15.98%)

, VVUS

VIVUS

$2.73 /

-0.065 (-2.33%)

, SIVB

SVB Financial

$253.78 /

+1.99 (+0.79%)

, VRML

Vermillion

$0.84 /

+0.036 (+4.48%)

, VKTX

Viking Therapeutics

$7.31 /

-0.4 (-5.19%)

Biotech Showcase 2020…

Biotech Showcase 2020 will be held in San Francisco on January 13-15.

ShowHide Related Items >><<
A Agilent
$87.45 /

-0.19 (-0.22%)

01/07/20 Wells Fargo
Wells Fargo initiates Life Science Tools, Services, Diagnostics Sector
01/07/20 Wells Fargo
Agilent initiated with an Overweight at Wells Fargo
01/06/20 Citi
Agilent initiated with a Neutral at Citi
11/26/19 JPMorgan
Agilent price target raised to $90 from $85 at JPMorgan
AGE AgeX Therapeutics
$1.72 /

-0.15 (-8.02%)

ALNY Alnylam
$114.80 /

-4.57 (-3.83%)

12/18/19 Cantor Fitzgerald
Alnylam price target raised to $176 from $159 at Cantor Fitzgerald
12/17/19 Piper Sandler
Alnylam price target raised to $155 from $145 at Piper Jaffray
11/25/19 Stifel
Alnylam one of few mid-caps with 'plausible large-cap aspirations,' says Stifel
11/25/19 BMO Capital
Alnylam price target raised to $143 from $138 at BMO Capital
AZN AstraZeneca
$49.68 /

-0.17 (-0.34%)

01/13/20 Roth Capital
Amarin's Vascepa now the 'go-to' after competitor failures, says Roth Capital
01/13/20 Stifel
Amarin should rally on failure of two potential competitors, says Stifel
01/13/20 JPMorgan
Epanova discontinuation positive for Amarin, says JPMorgan
12/26/19 Stifel
Stifel sees path to $230 for Iqvia shares after 'significant' AstraZeneca win
BAYRY Bayer
$0.00 /

+ (+0.00%)

12/19/19 BofA
Elanco upgraded to Buy from Neutral at BofA/Merrill
12/17/19 Berenberg
Bayer upgraded to Buy from Hold at Berenberg
12/17/19 Berenberg
Bayer upgraded to Buy from Hold at Berenberg
10/21/19 Piper Sandler
Piper reiterates Overweight on Crispr Therapeutics with $100 price target
BCLI BrainStorm
$4.38 /

+0.01 (+0.23%)

ENTX Entera Bio
$2.81 /

+0.13 (+4.85%)

DYAI Dyadic International
$5.64 /

-0.055 (-0.97%)

10/16/19 Dawson James
Dyadic International initiated with a Buy at Dawson James
DTIL Precision BioSciences
$13.52 /

-1.19 (-8.09%)

09/16/19 H.C. Wainwright
Precision IND accepted a quarter sooner than expected, says H.C. Wainwright
08/09/19 BTIG
Precision BioSciences initiated with a Buy at BTIG
08/09/19 BTIG
Precision BioSciences initiated with a Buy at BTIG
04/22/19 Jefferies
Precision BioSciences initiated with a Buy at Jefferies
DD DuPont
$60.41 /

+0.7 (+1.17%)

01/08/20 Spin-Off Research
DuPont upgraded to Buy from Hold at Spin-Off Research
12/18/19 DZ Bank
DuPont upgraded to Buy from Hold at DZ Bank
12/17/19 JPMorgan
IFF shares can rally 50% over three years, says JPMorgan
12/17/19 Jefferies
DuPont price target lowered to $79 from $85 at Jefferies
CYCC Cyclacel Pharmaceuticals
$0.80 /

-0.115 (-12.64%)

CTLT Catalent
$59.46 /

+1.77 (+3.07%)

10/17/19 Stephens
Catalent resumed with an Overweight at Stephens
08/28/19
Fly Intel: Top five analyst downgrades
08/28/19 Baird
Catalent price target raised to $60 from $50 at Baird
08/28/19
Catalent downgraded to Sector Weight on valuation at KeyBanc
COWN Cowen Group
$16.54 /

+0.24 (+1.47%)

07/23/19 Buckingham
Cowen Group initiated with a Buy at Buckingham
GMAB Genmab
$22.65 /

-0.02 (-0.09%)

01/13/20 Truist
Genmab initiated with a Buy at SunTrust
01/02/20 Guggenheim
Incyte downgraded to Neutral after strong 2019 at Guggenheim
12/12/19 Deutsche Bank
Genmab downgraded to Hold from Buy at Deutsche Bank
10/04/19 Guggenheim
Guggenheim positively biased on Biotech heading into earnings
IDXG Interpace Biosciences
$0.62 /

-0.0289 (-4.45%)

09/25/19 Oppenheimer
Oppenheimer starts Interpace at Outperform, sees 'clear path to BioPharma'
09/25/19 Oppenheimer
Interpace Diagnostics initiated with an Outperform at Oppenheimer
LCTX Lineage Cell Therapeutics
$0.76 /

-0.002 (-0.26%)

PHIO Phio Pharmaceuticals
$0.18 /

-0.0225 (-10.95%)

PJC Symbol now PIPR
$0.00 /

+ (+0.00%)

10/04/19 Buckingham
Piper Jaffray initiated with a Neutral at Buckingham
10/04/19 Buckingham
Piper Jaffray initiated with a Neutral rating at Buckingham
TNXP Tonix Pharmaceuticals
$1.45 /

-0.14 (-8.81%)

08/30/19 Roth Capital
Tonix Pharmaceuticals price target lowered to $1.30 from $4 at Roth Capital
04/18/19
Tonix Pharmaceuticals upgraded to Buy at Roth Capital
04/18/19 Roth Capital
Tonix Pharmaceuticals upgraded to Buy from Neutral at Roth Capital
TROV Changed name to CRDF
$1.32 /

+0.075 (+6.05%)

03/01/19 Maxim
Trovagene price target lowered to $8 from $18 at Maxim
VCYT Veracyte
$28.41 /

-0.49 (-1.70%)

12/04/19 Lake Street
Veracyte answered key question with NanoString pact, says Lake Street
07/31/19
Fly Intel: Top five analyst initiations
07/31/19 Lake Street
Veracyte initiated with a Buy at Lake Street
07/02/19
Fly Intel: Top five analyst initiations
VIE Viela Bio
$32.93 /

+2.84 (+9.44%)

10/28/19 Guggenheim
Guggenheim starts Viela Bio at Buy, makes stock Best Idea
10/28/19 Morgan Stanley
Viela Bio initiated with an Overweight at Morgan Stanley
10/28/19 Cowen
Viela Bio initiated with an Outperform at Cowen
10/28/19 Goldman Sachs
Viela Bio initiated with a Buy at Goldman Sachs
PSTV Plus Therapeutics
$2.79 /

-0.05 (-1.76%)

RDUS Radius Health
$18.37 /

-1.05 (-5.41%)

11/06/19 SVB Leerink
Radius Health price target lowered to $35 from $49 at SVB Leerink
08/29/19 Citi
Radius Health upgraded to Buy from Neutral at Citi
05/30/19 Citi
Radius Health assumed with a Neutral at Citi
05/29/19 Goldman Sachs
Radius Health upgraded to Buy from Neutral at Goldman Sachs
MRNA Moderna
$20.22 /

+1.12 (+5.86%)

01/10/20 Roth Capital
Moderna 'inching closer to a blockbuster CMV vaccine,' says Roth Capital
12/03/19 BofA
Moderna resumed with a Buy at BofA/Merrill
10/25/19 Roth Capital
Moderna initiated with a Buy at Roth Capital
09/13/19 Piper Sandler
Moderna price target raised to $32 from $30 at Piper Jaffray
MRK Merck
$89.43 /

-0.08 (-0.09%)

01/07/20
Fly Intel: Top five analyst initiations
01/07/20 SVB Leerink
OS miss in 1L SCLC 'a disappointing start to 2020' for Merck, says SVB Leerink
01/06/20 RBC Capital
Merck initiated with a Sector Perform at RBC Capital
12/18/19 Morgan Stanley
Morgan Stanley upgrades Major Pharmaceuticals sector view to Attractive
NAVB Navidea
$1.52 /

+ (+0.00%)

11/22/19 H.C. Wainwright
Navidea initiated with a Buy at H.C. Wainwright
07/11/19
Fly Intel: Top five analyst initiations
07/11/19 Maxim
Navidea initiated with a Buy at Maxim
07/11/19 Maxim
Navidea initiated with a Buy at Maxim
NBSE NeuBase Therapeutics
$6.50 /

-0.51 (-7.28%)

11/20/19 Oppenheimer
NeuBase Therapeutics initiated with an Outperform at Oppenheimer
10/29/19 H.C. Wainwright
NeuBase Therapeutics initiated with a Buy at H.C. Wainwright
09/24/19 BTIG
NeuBase Therapeutics initiated with a Buy at BTIG
NVO Novo Nordisk
$58.96 /

+0.27 (+0.46%)

01/03/20 Guggenheim
Novo Nordisk downgraded to Neutral on continued insulin headwinds at Guggenheim
01/03/20 Guggenheim
Novo Nordisk downgraded to Neutral from Buy at Guggenheim
11/22/19 Pareto
Novo Nordisk downgraded to Hold from Buy at Pareto
11/19/19 Truist
Dicerna price target raised to $28 from $24 at SunTrust
NVS Novartis
$93.71 /

-0.165 (-0.18%)

01/06/20 JPMorgan
JPMorgan upgrades Sanofi to Overweight on 'unjustified' valuation gap
12/18/19 H.C. Wainwright
Aduro Biotech price target lowered to $4 from $7 at H.C. Wainwright
12/16/19 Evercore ISI
Evercore downgrades Regeneron on Eylea risk from Beovu
12/16/19
Novartis ends development of fevipiprant in asthma after Phase III failure
OVID Ovid Therapeutics
$3.50 /

-0.35 (-9.09%)

09/24/19 Citi
Ovid Therapeutics price target raised to $10 from $8 at Citi
09/23/19 Piper Sandler
Piper says Ovid shares reflect little value for 'exciting' soticlestat program
09/04/19 RBC Capital
Ovid Therapeutics initiated with an Outperform at RBC Capital
03/10/19 Piper Sandler
Ovid Therapeutics price target lowered to $14 from $20 at Piper Jaffray
STI Merged to become TFC
$0.00 /

+ (+0.00%)

12/09/19 RBC Capital
PNC Financial downgraded to Outperform from Top Pick at RBC Capital
11/20/19 Janney Montgomery Scott
SunTrust downgraded to Neutral from Buy at Janney Montgomery Scott
11/11/19 Janney Montgomery Scott
Janney Montgomery Scott downgrades BB&T to Neutral, says premium may 'flatten'
10/08/19 Jefferies
Jefferies changes five bank ratings after looking into 2020, 2021
XON Intrexon
$6.74 /

+0.3 (+4.66%)

06/18/19 JMP Securities
Surterra cannabinoid pact a positive for Intrexon, says JMP Securities
03/01/19 Northland
Intrexon downgraded to Market Perform from Outperform at Northland
SLRX Salarius Pharmaceuticals
$3.05 /

-0.58 (-15.98%)

VVUS VIVUS
$2.73 /

-0.065 (-2.33%)

SIVB SVB Financial
$253.78 /

+1.99 (+0.79%)

01/09/20 BofA
SVB Financial named top pick for 2020 at BofA
01/09/20 BofA
Amazaon, Wix.com, & SVB Financial added to US 1 List at BofA
01/02/20 Truist
SunTrust raises price targets on select regional banks on improved margins
08/13/19 JPMorgan
JPMorgan sees 'tremendous buying opportunity' into SVB Financial shares
VRML Vermillion
$0.84 /

+0.036 (+4.48%)

12/16/19
Vermillion management to meet with William Blair
VKTX Viking Therapeutics
$7.31 /

-0.4 (-5.19%)

11/21/19 Truist
Viking posting for VOYAGER includes 'nothing concerning,' says SunTrust
07/15/19 Oppenheimer
Viking Therapeutics initiated with an Outperform at Oppenheimer
06/25/19 Stifel
Viking Therapeutics initiated with a Buy at Stifel
06/25/19 Stifel
Madrigal Pharmaceuticals initiated with a Hold at Stifel
Conference/Events
EBDF Group to hold a conference » 08:42
01/13/20
01/13
08:42
01/13/20
08:42
A

Agilent

$87.64 /

+0.32 (+0.37%)

, AGE

AgeX Therapeutics

$1.87 /

-0.01 (-0.53%)

, ALNY

Alnylam

$119.37 /

+1.36 (+1.15%)

, AZN

AstraZeneca

$49.85 /

-0.24 (-0.48%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, BCLI

BrainStorm

$4.37 /

+0.02 (+0.46%)

, ENTX

Entera Bio

$2.68 /

+0.08 (+3.08%)

, DYAI

Dyadic International

$5.69 /

+0.36 (+6.75%)

, DTIL

Precision BioSciences

$14.71 /

+0.02 (+0.14%)

, DD

DuPont

$59.71 /

-1.25 (-2.05%)

, CYCC

Cyclacel Pharmaceuticals

$0.91 /

+0.1578 (+20.98%)

, CTLT

Catalent

$57.69 /

+0.73 (+1.28%)

, COWN

Cowen Group

$16.30 /

-0.25 (-1.51%)

, GMAB

Genmab

$22.67 /

+ (+0.00%)

, IDXG

Interpace Biosciences

$0.65 /

+0.0189 (+3.00%)

, LCTX

Lineage Cell Therapeutics

$0.76 /

-0.018 (-2.31%)

, PHIO

Phio Pharmaceuticals

$0.21 /

-0.023 (-9.83%)

, PJC

Symbol now PIPR

$0.00 /

+ (+0.00%)

, TNXP

Tonix Pharmaceuticals

$1.59 /

+ (+0.00%)

, TROV

Changed name to CRDF

$1.24 /

-0.02 (-1.59%)

, VCYT

Veracyte

$28.90 /

+0.45 (+1.58%)

, VIE

Viela Bio

$30.09 /

+1.07 (+3.69%)

, PSTV

Plus Therapeutics

$2.84 /

+0.13 (+4.80%)

, RDUS

Radius Health

$19.42 /

-1.07 (-5.22%)

, MRNA

Moderna

$19.10 /

+0.71 (+3.86%)

, MRK

Merck

$89.51 /

+0.11 (+0.12%)

, NAVB

Navidea

$1.52 /

+0.005 (+0.33%)

, NBSE

NeuBase Therapeutics

$7.01 /

-0.36 (-4.88%)

, NVO

Novo Nordisk

$58.69 /

+1.25 (+2.18%)

, NVS

Novartis

$93.87 /

-0.88 (-0.93%)

, OVID

Ovid Therapeutics

$3.85 /

-0.18 (-4.47%)

, STI

Merged to become TFC

$0.00 /

+ (+0.00%)

, XON

Intrexon

$6.44 /

+0.14 (+2.22%)

, SLRX

Salarius Pharmaceuticals

$3.63 /

+0.03 (+0.83%)

, VVUS

VIVUS

$2.79 /

-0.03 (-1.06%)

, SIVB

SVB Financial

$251.79 /

-4.15 (-1.62%)

, VRML

Vermillion

$0.80 /

-0.016 (-1.95%)

, VKTX

Viking Therapeutics

$7.71 /

-0.02 (-0.26%)

Biotech Showcase 2020…

Biotech Showcase 2020 will be held in San Francisco on January 13-15.

ShowHide Related Items >><<
A Agilent
$87.64 /

+0.32 (+0.37%)

01/07/20 Wells Fargo
Wells Fargo initiates Life Science Tools, Services, Diagnostics Sector
01/07/20 Wells Fargo
Agilent initiated with an Overweight at Wells Fargo
01/06/20 Citi
Agilent initiated with a Neutral at Citi
11/26/19 JPMorgan
Agilent price target raised to $90 from $85 at JPMorgan
AGE AgeX Therapeutics
$1.87 /

-0.01 (-0.53%)

ALNY Alnylam
$119.37 /

+1.36 (+1.15%)

12/18/19 Cantor Fitzgerald
Alnylam price target raised to $176 from $159 at Cantor Fitzgerald
12/17/19 Piper Sandler
Alnylam price target raised to $155 from $145 at Piper Jaffray
11/25/19 Stifel
Alnylam one of few mid-caps with 'plausible large-cap aspirations,' says Stifel
11/25/19 BMO Capital
Alnylam price target raised to $143 from $138 at BMO Capital
AZN AstraZeneca
$49.85 /

-0.24 (-0.48%)

12/26/19 Stifel
Stifel sees path to $230 for Iqvia shares after 'significant' AstraZeneca win
12/19/19 Baird
AstraZeneca deal a 'landmark win' for Iqvia OCE solution, says Baird
12/19/19 KeyBanc
Iqvia win at AstraZeneca at loss for Veeva, says KeyBanc
12/16/19 Stifel
Stifel 'taking profits' on Amarin following FDA approval, downgrades to Hold
BAYRY Bayer
$0.00 /

+ (+0.00%)

12/19/19 BofA
Elanco upgraded to Buy from Neutral at BofA/Merrill
12/17/19 Berenberg
Bayer upgraded to Buy from Hold at Berenberg
12/17/19 Berenberg
Bayer upgraded to Buy from Hold at Berenberg
10/21/19 Piper Sandler
Piper reiterates Overweight on Crispr Therapeutics with $100 price target
BCLI BrainStorm
$4.37 /

+0.02 (+0.46%)

ENTX Entera Bio
$2.68 /

+0.08 (+3.08%)

DYAI Dyadic International
$5.69 /

+0.36 (+6.75%)

10/16/19 Dawson James
Dyadic International initiated with a Buy at Dawson James
DTIL Precision BioSciences
$14.71 /

+0.02 (+0.14%)

09/16/19 H.C. Wainwright
Precision IND accepted a quarter sooner than expected, says H.C. Wainwright
08/09/19 BTIG
Precision BioSciences initiated with a Buy at BTIG
08/09/19 BTIG
Precision BioSciences initiated with a Buy at BTIG
04/22/19 Jefferies
Precision BioSciences initiated with a Buy at Jefferies
DD DuPont
$59.71 /

-1.25 (-2.05%)

01/08/20 Spin-Off Research
DuPont upgraded to Buy from Hold at Spin-Off Research
12/18/19 DZ Bank
DuPont upgraded to Buy from Hold at DZ Bank
12/17/19 JPMorgan
IFF shares can rally 50% over three years, says JPMorgan
12/17/19 Jefferies
DuPont price target lowered to $79 from $85 at Jefferies
CYCC Cyclacel Pharmaceuticals
$0.91 /

+0.1578 (+20.98%)

CTLT Catalent
$57.69 /

+0.73 (+1.28%)

10/17/19 Stephens
Catalent resumed with an Overweight at Stephens
08/28/19
Fly Intel: Top five analyst downgrades
08/28/19 Baird
Catalent price target raised to $60 from $50 at Baird
08/28/19
Catalent downgraded to Sector Weight on valuation at KeyBanc
COWN Cowen Group
$16.30 /

-0.25 (-1.51%)

07/23/19 Buckingham
Cowen Group initiated with a Buy at Buckingham
GMAB Genmab
$22.67 /

+ (+0.00%)

01/13/20 Truist
Genmab initiated with a Buy at SunTrust
01/02/20 Guggenheim
Incyte downgraded to Neutral after strong 2019 at Guggenheim
12/12/19 Deutsche Bank
Genmab downgraded to Hold from Buy at Deutsche Bank
10/04/19 Guggenheim
Guggenheim positively biased on Biotech heading into earnings
IDXG Interpace Biosciences
$0.65 /

+0.0189 (+3.00%)

09/25/19 Oppenheimer
Oppenheimer starts Interpace at Outperform, sees 'clear path to BioPharma'
09/25/19 Oppenheimer
Interpace Diagnostics initiated with an Outperform at Oppenheimer
LCTX Lineage Cell Therapeutics
$0.76 /

-0.018 (-2.31%)

PHIO Phio Pharmaceuticals
$0.21 /

-0.023 (-9.83%)

PJC Symbol now PIPR
$0.00 /

+ (+0.00%)

10/04/19 Buckingham
Piper Jaffray initiated with a Neutral at Buckingham
10/04/19 Buckingham
Piper Jaffray initiated with a Neutral rating at Buckingham
TNXP Tonix Pharmaceuticals
$1.59 /

+ (+0.00%)

08/30/19 Roth Capital
Tonix Pharmaceuticals price target lowered to $1.30 from $4 at Roth Capital
04/18/19
Tonix Pharmaceuticals upgraded to Buy at Roth Capital
04/18/19 Roth Capital
Tonix Pharmaceuticals upgraded to Buy from Neutral at Roth Capital
TROV Changed name to CRDF
$1.24 /

-0.02 (-1.59%)

03/01/19 Maxim
Trovagene price target lowered to $8 from $18 at Maxim
VCYT Veracyte
$28.90 /

+0.45 (+1.58%)

12/04/19 Lake Street
Veracyte answered key question with NanoString pact, says Lake Street
07/31/19
Fly Intel: Top five analyst initiations
07/31/19 Lake Street
Veracyte initiated with a Buy at Lake Street
07/02/19
Fly Intel: Top five analyst initiations
VIE Viela Bio
$30.09 /

+1.07 (+3.69%)

10/28/19 Guggenheim
Guggenheim starts Viela Bio at Buy, makes stock Best Idea
10/28/19 Morgan Stanley
Viela Bio initiated with an Overweight at Morgan Stanley
10/28/19 Cowen
Viela Bio initiated with an Outperform at Cowen
10/28/19 Goldman Sachs
Viela Bio initiated with a Buy at Goldman Sachs
PSTV Plus Therapeutics
$2.84 /

+0.13 (+4.80%)

RDUS Radius Health
$19.42 /

-1.07 (-5.22%)

11/06/19 SVB Leerink
Radius Health price target lowered to $35 from $49 at SVB Leerink
08/29/19 Citi
Radius Health upgraded to Buy from Neutral at Citi
05/30/19 Citi
Radius Health assumed with a Neutral at Citi
05/29/19 Goldman Sachs
Radius Health upgraded to Buy from Neutral at Goldman Sachs
MRNA Moderna
$19.10 /

+0.71 (+3.86%)

01/10/20 Roth Capital
Moderna 'inching closer to a blockbuster CMV vaccine,' says Roth Capital
12/03/19 BofA
Moderna resumed with a Buy at BofA/Merrill
10/25/19 Roth Capital
Moderna initiated with a Buy at Roth Capital
09/13/19 Piper Sandler
Moderna price target raised to $32 from $30 at Piper Jaffray
MRK Merck
$89.51 /

+0.11 (+0.12%)

01/07/20
Fly Intel: Top five analyst initiations
01/07/20 SVB Leerink
OS miss in 1L SCLC 'a disappointing start to 2020' for Merck, says SVB Leerink
01/06/20 RBC Capital
Merck initiated with a Sector Perform at RBC Capital
12/18/19 Morgan Stanley
Morgan Stanley upgrades Major Pharmaceuticals sector view to Attractive
NAVB Navidea
$1.52 /

+0.005 (+0.33%)

11/22/19 H.C. Wainwright
Navidea initiated with a Buy at H.C. Wainwright
07/11/19
Fly Intel: Top five analyst initiations
07/11/19 Maxim
Navidea initiated with a Buy at Maxim
07/11/19 Maxim
Navidea initiated with a Buy at Maxim
NBSE NeuBase Therapeutics
$7.01 /

-0.36 (-4.88%)

11/20/19 Oppenheimer
NeuBase Therapeutics initiated with an Outperform at Oppenheimer
10/29/19 H.C. Wainwright
NeuBase Therapeutics initiated with a Buy at H.C. Wainwright
09/24/19 BTIG
NeuBase Therapeutics initiated with a Buy at BTIG
NVO Novo Nordisk
$58.69 /

+1.25 (+2.18%)

01/03/20 Guggenheim
Novo Nordisk downgraded to Neutral on continued insulin headwinds at Guggenheim
01/03/20 Guggenheim
Novo Nordisk downgraded to Neutral from Buy at Guggenheim
11/22/19 Pareto
Novo Nordisk downgraded to Hold from Buy at Pareto
11/19/19 Truist
Dicerna price target raised to $28 from $24 at SunTrust
NVS Novartis
$93.87 /

-0.88 (-0.93%)

01/06/20 JPMorgan
JPMorgan upgrades Sanofi to Overweight on 'unjustified' valuation gap
12/18/19 H.C. Wainwright
Aduro Biotech price target lowered to $4 from $7 at H.C. Wainwright
12/16/19 Evercore ISI
Evercore downgrades Regeneron on Eylea risk from Beovu
12/16/19
Novartis ends development of fevipiprant in asthma after Phase III failure
OVID Ovid Therapeutics
$3.85 /

-0.18 (-4.47%)

09/24/19 Citi
Ovid Therapeutics price target raised to $10 from $8 at Citi
09/23/19 Piper Sandler
Piper says Ovid shares reflect little value for 'exciting' soticlestat program
09/04/19 RBC Capital
Ovid Therapeutics initiated with an Outperform at RBC Capital
03/10/19 Piper Sandler
Ovid Therapeutics price target lowered to $14 from $20 at Piper Jaffray
STI Merged to become TFC
$0.00 /

+ (+0.00%)

12/09/19 RBC Capital
PNC Financial downgraded to Outperform from Top Pick at RBC Capital
11/20/19 Janney Montgomery Scott
SunTrust downgraded to Neutral from Buy at Janney Montgomery Scott
11/11/19 Janney Montgomery Scott
Janney Montgomery Scott downgrades BB&T to Neutral, says premium may 'flatten'
10/08/19 Jefferies
Jefferies changes five bank ratings after looking into 2020, 2021
XON Intrexon
$6.44 /

+0.14 (+2.22%)

06/18/19 JMP Securities
Surterra cannabinoid pact a positive for Intrexon, says JMP Securities
03/01/19 Northland
Intrexon downgraded to Market Perform from Outperform at Northland
SLRX Salarius Pharmaceuticals
$3.63 /

+0.03 (+0.83%)

VVUS VIVUS
$2.79 /

-0.03 (-1.06%)

SIVB SVB Financial
$251.79 /

-4.15 (-1.62%)

01/09/20 BofA
SVB Financial named top pick for 2020 at BofA
01/09/20 BofA
Amazaon, Wix.com, & SVB Financial added to US 1 List at BofA
01/02/20 Truist
SunTrust raises price targets on select regional banks on improved margins
08/13/19 JPMorgan
JPMorgan sees 'tremendous buying opportunity' into SVB Financial shares
VRML Vermillion
$0.80 /

-0.016 (-1.95%)

12/16/19
Vermillion management to meet with William Blair
VKTX Viking Therapeutics
$7.71 /

-0.02 (-0.26%)

11/21/19 Truist
Viking posting for VOYAGER includes 'nothing concerning,' says SunTrust
07/15/19 Oppenheimer
Viking Therapeutics initiated with an Outperform at Oppenheimer
06/25/19 Stifel
Viking Therapeutics initiated with a Buy at Stifel
06/25/19 Stifel
Madrigal Pharmaceuticals initiated with a Hold at Stifel
Recommendations
Vermillion management to meet with William Blair » 04:55
12/16/19
12/16
04:55
12/16/19
04:55
VRML

Vermillion

$0.76 /

+0.0176 (+2.37%)

Group Luncheon Meeting…

Group Luncheon Meeting with Management to be held in the New York area on December 16 at 12:30 pm hosted by William Blair.

ShowHide Related Items >><<

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.